Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bader, Michael Prof. Dr. (1) Dechend, Ralf Priv. Doz. (21) Herse, Florian PD Dr. (3) Heuser, Arnd Dr. (1) Janke, Jürgen Dr. (2) Luft, Friedrich Prof. Dr. (27) Niendorf, Thoralf Prof. Dr. (9) Pilz, Bernhard Dr. (1) Qadri, Fatimunnisa Dr. (2) Rahn, Hans-Peter Dr. (1) Scheidereit, Claus Prof. Dr. (1) Todiras, Mihail (1) Waiczies, Helmar Dr. (1) Wallukat, Gerd Dr. (3) Wellner, Maren Dr. (3) Wenzel, Katrin Dr. (2) (-) Müller, Dominik Prof. Dr. (30) 1995 (1) 1997 (1) 1998 (3) 1999 (3) 2000 (6) (-) 2001 (12) 2002 (8) 2003 (5) (-) 2004 (6) 2005 (10) 2006 (4) 2007 (14) 2008 (18) (-) 2009 (15) 2010 (15) 2011 (13) 2012 (13) 2013 (22) 2014 (14) 2015 (20) 2016 (18) 2017 (20) 2018 (17) 2019 (22) 2020 (29) 2021 (40) 2022 (10) 2023 (11) 2024 (2) AG Müller/Dechend (ECRC) (30) Animal Phenotyping (2) Biology of Malignant Lymphomas (1) Developmental Biology / Signal Transduction (2) (-) Experimental Ultrahigh-Field MR (3) Genetics of Congenital Heart Disease (1) (-) Hypertension-caused End-Organ Damage (30) Hypertension-Mediated End-Organ Damage (30) Magnetic Resonance (3) Mobile DNA (1) Molecular Biology of Peptide Hormones (4) Proteome Dynamics (1) Translational Oncology of Solid Tumors (2) 33 Results: Active Filter: Müller, Dominik Prof. Dr.Experimental Ultrahigh-Field MRHypertension-caused End-Organ Damage200120042009 Sort: Result score Newest to oldest Oldest to newest January 01, 2001 / Hypertension Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats Z.J. Cheng T. Vaskonen I. Tikkanen K. Nurminen H. Ruskoaho H. Vapaatalo D. Muller J.K. Park F.C. Luft E.M.A. Mervaala January 01, 2001 / Hypertension Mineralocorticoid receptor affects AP-1 and nuclear factor-kappa B activation in angiotensin II-induced cardiac injury A. Fiebeler F. Schmidt D.N. Mueller J.K. Park R. Dechend M. Bieringer E. Shagdarsuren V. Breu H. Haller F.C. Luft January 01, 2001 / Hypertension Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes E.M.A. Mervaala Z.J. Cheng I. Tikkanen R. Lapatto K. Nurminen H. Vapaatalo D.N. Mueller A. Fiebeler U. Ganten D. Ganten F.C. Luft January 01, 2001 / J Mol Med Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research M. Bader J. Peters O. Baltatu D.N. Mueller F.C. Luft D. Ganten January 01, 2001 / Am J Hypertens Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition R. Dechend A. Fiebler C. Lindschau H. Bischoff D.N. Mueller J.K. Park R. Dietz H. Haller F.C. Luft January 01, 2001 / FASEB J Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organ damage D.N. Mueller V. Heissmeyer R. Dechend F. Hampich J.K. Park A. Fiebeler E. Shagdarsuren J. Theuer M. Elger B. Pilz V. Breu K. Schroer D. Ganten R. Dietz H. Haller C. Scheidereit F.C. Luft January 01, 2001 / Circulation Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor R. Dechend A. Fiebeler J.K. Park D.N. Muller J. Theuer E. Mervaala M. Bieringer D. Gulba R. Dietz F.C. Luft H. Haller August 01, 2001 / Hypertension Renin uptake by the endothelium mediates vascular angiotensin formation K.F. Hilgers R. Veelken D.N. Mueller H. Kohler A. Hartner S.R. Botkin C. Stumpf R.E. Schmieder R.A. Gomez March 01, 2001 / Farmaco Piperidine renin inhibitors: from leads to drug candidates H.P. Maerki A. Binggeli B. Bittner V. Bohner-Lang V. Breu D. Bur P.H. Coassolo J.P. Clozel A. D'Arcy H. Doebeli W. Fischli C.H. Funk J. Foricher T. Giller F. Grueninger A. Guenzi R. Gueller T. Hartung G. Hirth C.H. Jenny M. Kansy U. Klinkhammer T. Lave B. Lohri F.C. Luft E.M. Mervaala D.N. Mueller M. Mueller F. Montavon C.H. Oefner C. Qiu A. Reichel P. Sanwald-Ducray M. Scalone M. Schleimer R. Schmid H. Treiber A. Treiber O. Valdenaire E. Vieira P. Waldmeier R. Wiegand-Chou M. Wilhelm W. Wostl M. Zell R. Zell April 01, 2001 / Contrib Nephrol Angiotensin-induced inflammation and vascular injury D.N. Mueller R. Dechend A. Fiebeler J.K. Park H. Haller F.C. Luft Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
January 01, 2001 / Hypertension Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats Z.J. Cheng T. Vaskonen I. Tikkanen K. Nurminen H. Ruskoaho H. Vapaatalo D. Muller J.K. Park F.C. Luft E.M.A. Mervaala
January 01, 2001 / Hypertension Mineralocorticoid receptor affects AP-1 and nuclear factor-kappa B activation in angiotensin II-induced cardiac injury A. Fiebeler F. Schmidt D.N. Mueller J.K. Park R. Dechend M. Bieringer E. Shagdarsuren V. Breu H. Haller F.C. Luft
January 01, 2001 / Hypertension Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes E.M.A. Mervaala Z.J. Cheng I. Tikkanen R. Lapatto K. Nurminen H. Vapaatalo D.N. Mueller A. Fiebeler U. Ganten D. Ganten F.C. Luft
January 01, 2001 / J Mol Med Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research M. Bader J. Peters O. Baltatu D.N. Mueller F.C. Luft D. Ganten
January 01, 2001 / Am J Hypertens Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition R. Dechend A. Fiebler C. Lindschau H. Bischoff D.N. Mueller J.K. Park R. Dietz H. Haller F.C. Luft
January 01, 2001 / FASEB J Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organ damage D.N. Mueller V. Heissmeyer R. Dechend F. Hampich J.K. Park A. Fiebeler E. Shagdarsuren J. Theuer M. Elger B. Pilz V. Breu K. Schroer D. Ganten R. Dietz H. Haller C. Scheidereit F.C. Luft
January 01, 2001 / Circulation Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor R. Dechend A. Fiebeler J.K. Park D.N. Muller J. Theuer E. Mervaala M. Bieringer D. Gulba R. Dietz F.C. Luft H. Haller
August 01, 2001 / Hypertension Renin uptake by the endothelium mediates vascular angiotensin formation K.F. Hilgers R. Veelken D.N. Mueller H. Kohler A. Hartner S.R. Botkin C. Stumpf R.E. Schmieder R.A. Gomez
March 01, 2001 / Farmaco Piperidine renin inhibitors: from leads to drug candidates H.P. Maerki A. Binggeli B. Bittner V. Bohner-Lang V. Breu D. Bur P.H. Coassolo J.P. Clozel A. D'Arcy H. Doebeli W. Fischli C.H. Funk J. Foricher T. Giller F. Grueninger A. Guenzi R. Gueller T. Hartung G. Hirth C.H. Jenny M. Kansy U. Klinkhammer T. Lave B. Lohri F.C. Luft E.M. Mervaala D.N. Mueller M. Mueller F. Montavon C.H. Oefner C. Qiu A. Reichel P. Sanwald-Ducray M. Scalone M. Schleimer R. Schmid H. Treiber A. Treiber O. Valdenaire E. Vieira P. Waldmeier R. Wiegand-Chou M. Wilhelm W. Wostl M. Zell R. Zell
April 01, 2001 / Contrib Nephrol Angiotensin-induced inflammation and vascular injury D.N. Mueller R. Dechend A. Fiebeler J.K. Park H. Haller F.C. Luft